DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
出版年份 2019 全文链接
标题
DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-26
DOI
10.1186/s13046-019-1442-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interleukin-6 determines protein stabilization of DNA methyltransferases and alters DNA promoter methylation of genes associated with insulin signaling and angiogenesis
- (2018) Aswath Balakrishnan et al. LABORATORY INVESTIGATION
- Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
- (2018) Otília Menyhárt et al. Royal Society Open Science
- FGF19/FGFR4 signaling contributes to the resistance of hepatocellular carcinoma to sorafenib
- (2017) Lixia Gao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma
- (2017) Jianhua Liu et al. ONCOLOGY REPORTS
- Implications of FGF19 on sorafenib-mediated nitric oxide production in hepatocellular carcinoma cells - a short report
- (2017) Lixia Gao et al. CELLULAR ONCOLOGY
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
- (2016) Andrew P. Feinberg et al. NATURE REVIEWS GENETICS
- DNA methyltransferase 1, 3a, and 3b expression in hepatitis C associated human hepatocellular carcinoma and their clinicopathological association
- (2016) Nadir Naveed Siddiqui et al. TUMOR BIOLOGY
- An overview of microRNAs
- (2015) Scott M. Hammond ADVANCED DRUG DELIVERY REVIEWS
- Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
- (2015) Te-Sheng Chang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Activation of IL6/IGFIR Confers Poor Prognosis of HBV-Related Hepatocellular Carcinoma through Induction of OCT4/NANOG Expression
- (2015) T.-S. Chang et al. CLINICAL CANCER RESEARCH
- Global Epidemiology of Hepatocellular Carcinoma
- (2015) Katherine A. McGlynn et al. Clinics in Liver Disease
- Whole-genome fingerprint of the DNA methylome during human B cell differentiation
- (2015) Marta Kulis et al. NATURE GENETICS
- SRY and OCT4 Are Required for the Acquisition of Cancer Stem Cell-Like Properties and Are Potential Differentiation Therapy Targets
- (2015) Shigekazu Murakami et al. STEM CELLS
- Versatile functions for IL-6 in metabolism and cancer
- (2015) Jan Mauer et al. TRENDS IN IMMUNOLOGY
- DNA methyltransferase 3b silencing affects locus-specific DNA methylation and inhibits proliferation, migration and invasion in human hepatocellular carcinoma SMMC-7721 and BEL-7402 cells
- (2015) JIA-CHEN WANG et al. Oncology Letters
- Epigenetic silencing of Oct4 by a complex containing SUV39H1 and Oct4 pseudogene lncRNA
- (2015) Michele Scarola et al. Nature Communications
- Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells
- (2014) Shanshan Wan et al. GASTROENTEROLOGY
- DNMT-dependent suppression of microRNA regulates the induction of GBM tumor-propagating phenotype by Oct4 and Sox2
- (2014) H Lopez-Bertoni et al. ONCOGENE
- Significance of DNMT3b in Oral Cancer
- (2014) Wen-Cheng Chen et al. PLoS One
- Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma
- (2014) Zhe Guo WORLD JOURNAL OF GASTROENTEROLOGY
- Virus induced inflammation and cancer development
- (2013) Scott A. Read et al. CANCER LETTERS
- Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma
- (2013) Lei Wang et al. CARCINOGENESIS
- Coexpression of Stemness Factors Oct4 and Nanog Predict Liver Resection
- (2012) Xin Yin et al. ANNALS OF SURGICAL ONCOLOGY
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer
- (2012) Yi Li et al. CARCINOGENESIS
- Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review
- (2012) Bingru Xie et al. DIGESTIVE DISEASES AND SCIENCES
- Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
- (2012) Kuen-Feng Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma
- (2012) Juanjuan Shan et al. HEPATOLOGY
- IL6-Mediated Suppression of miR-200c Directs Constitutive Activation of Inflammatory Signaling Circuit Driving Transformation and Tumorigenesis
- (2012) Matjaz Rokavec et al. MOLECULAR CELL
- Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
- (2012) S M Kumar et al. ONCOGENE
- miRNAs regulate stem cell self-renewal and differentiation
- (2012) Zuoren Yu et al. Frontiers in Genetics
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- NICE guidance on azacitidine for the treatment of myelodysplastic syndromes, chronic myelomonocytic leukaemia, and acute myeloid leukaemia
- (2011) Whitney Miller et al. LANCET ONCOLOGY
- Novel Anti-cancer Compounds for Developing Combinatorial Therapies to Target Anoikis-Resistant Tumors
- (2011) Lokesh Nagaprashantha et al. PHARMACEUTICAL RESEARCH
- Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway
- (2010) Xiao Qi Wang et al. HEPATOLOGY
- Upregulation of DNA Methyltransferase-Mediated Gene Silencing, Anchorage-Independent Growth, and Migration of Colon Cancer Cells by Interleukin-6
- (2010) E. Foran et al. MOLECULAR CANCER RESEARCH
- Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells
- (2010) D. Kuck et al. MOLECULAR CANCER THERAPEUTICS
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now